Randomized Clinical Trial for Clinical Response Evaluation in Crohn's Disease: Infliximab Versus Adalimumab

Otros

Fecha

2016-03-01

Registro en:

Inflammatory Bowel Diseases. Philadelphia: Lippincott Williams & Wilkins, v. 22, p. S30-S30, 2016.

1078-0998

http://hdl.handle.net/11449/165476

10.1097/01.MIB.0000480181.61935.67

WOS:000393896400092

Autor

Fac Med Botucatu

Universidade Estadual Paulista (Unesp)

Institución

Universidade Estadual Paulista (Brasil)

Materias

Mostrar el registro completo del ítem